Mkb Parmar

999 total citations · 1 hit paper
8 papers, 694 citations indexed

About

Mkb Parmar is a scholar working on Statistics and Probability, Pulmonary and Respiratory Medicine and Statistics, Probability and Uncertainty. According to data from OpenAlex, Mkb Parmar has authored 8 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Statistics and Probability, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Statistics, Probability and Uncertainty. Recurrent topics in Mkb Parmar's work include Statistical Methods in Clinical Trials (4 papers), Meta-analysis and systematic reviews (2 papers) and Renal cell carcinoma treatment (1 paper). Mkb Parmar is often cited by papers focused on Statistical Methods in Clinical Trials (4 papers), Meta-analysis and systematic reviews (2 papers) and Renal cell carcinoma treatment (1 paper). Mkb Parmar collaborates with scholars based in United Kingdom, India and Italy. Mkb Parmar's co-authors include Sarah Burdett, M Debevec, DJ Girling, R L Souhami, Kovač, RJ Stephens, Steven Piantadosi, Valter Torri, Jean‐Pierre Pignon and P Rocmans and has published in prestigious journals such as The Lancet, Cancer Research and British Journal of Cancer.

In The Last Decade

Mkb Parmar

8 papers receiving 669 citations

Hit Papers

Postoperative radiotherapy in non-small-cell lung cancer:... 1998 2026 2007 2016 1998 100 200 300 400 500

Peers

Mkb Parmar
Comparison fields: 5 of 49
  • Pulmonary and Respiratory Medicine 553
  • Oncology 212
  • Radiology, Nuclear Medicine and Imaging 158
  • Surgery 108
  • Radiation 91
Replace Kovač with:
Kovač Slovenia
M Debevec Slovenia
Julio Guerra Canada
J.D. Cox United States
M.V. Pilepich United States
Cheryl Pugh United Kingdom
Timothy A. Lin United States
William B. Fisher United States
N. Bayman United Kingdom
Bernardo H. L. Goulart United States
Kovač Slovenia View profile →
Citations per field, relative to Mkb Parmar
Mkb Parmar · 1×
Citations per year, relative to Mkb Parmar
Mkb Parmar · 1×

Countries citing papers authored by Mkb Parmar

Since Specialization
Citations

This map shows the geographic impact of Mkb Parmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mkb Parmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mkb Parmar more than expected).

Fields of papers citing papers by Mkb Parmar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mkb Parmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mkb Parmar. The network helps show where Mkb Parmar may publish in the future.

Co-authorship network of co-authors of Mkb Parmar

This figure shows the co-authorship network connecting the top 25 collaborators of Mkb Parmar. A scholar is included among the top collaborators of Mkb Parmar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mkb Parmar. Mkb Parmar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
# Work Indexed citations
1
Timely and reliable evaluation of the effects of interventions: a framework for adaptive meta-analysis (FAME)
6
2 1
3 24
4
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial (vol 361, pg 2099, 2003)
2
5 66
6
Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials breakdown →
580
7
Bayesian data monitoring in clinical trials
14
8
Discussion: M K B Parmar and David Machin, monitoring clinical trials; Experience of, and proposals under consideration by the Cancer Therapy Committee of the British Medical Research Council
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026